Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease

  • Jeffry S. Nyman
  • , Alyssa R. Merkel
  • , Sasidhar Uppuganti
  • , Bijaya Nayak
  • , Barbara Rowland
  • , Alexander J. Makowski
  • , Babatunde O. Oyajobi
  • , Julie A. Sterling

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology